Literature DB >> 31656148

Role of Cellular Biomolecules in Screening, Diagnosis and Treatment of Colorectal Cancer.

Xiang-Lin Mei1, Qing-Fan Zheng2.   

Abstract

BACKGROUND: Prevention is the primary strategy to avoid the occurrence and mortality of colorectal cancer. Generally, the concentrations of tumor markers tested during the diagnosis and believed to assist the detection of disease in the early stages of cancer. Some of the biomarkers are also important during treatment and real-time monitoring of the progress of treatment.
METHODS: We considered a rationale search of key references from the database of peer-reviewed research and review literatures of colorectal cancer. The topic of search was focused on the novel methods and modern techniques of Screening, Diagnosis, and Treatment of colorectal cancer. The screened publications were critically analysed using a deductive content analysis and the matter was put in separate headings and sub headings.
RESULTS: It was found that endoscopic examination, early detection, and surgery are some of the common strategies to manage colorectal cancer because late stages are difficult to treat due to the high-cost requirement and fewer chances of survival. As far as chemotherapy is concerned, systemic chemotherapy has been shown to offer the maximum benefit to patients with cancer metastasis. Among different chemotherapy measures, primary colorectal cancer prevention agents involve pharmaceuticals, phytochemicals, and dietary supplements are some of the standard options.
CONCLUSION: In this review article, we have provided a comprehensive analysis of different biomarkers for the detection of colorectal cancer as well as different formulations developed for efficient treatment of the disease. The use of dietary supplements, the combinatorial approach, and nanotechnology-based strategies for colorectal cancer diagnosis and treatment are some of the recent and modern methods of cancer management. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Colorectal cancer; angiogenesis; biomolecules; cancer diagnosis; cancer metastasis; drug delivery.

Mesh:

Substances:

Year:  2019        PMID: 31656148     DOI: 10.2174/1389200220666191018153428

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  4 in total

1.  Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.

Authors:  Muhammad Tarek Abdel Ghafar; Fatma Gharib; Sherief Abdel-Salam; Reham Abdelkader Elkhouly; Ahmed Elshora; Khaled H Shalaby; Dina El-Guindy; Mohamed Ali El-Rashidy; Nema A Soliman; Mira Maged Abu-Elenin; Alzahraa A Allam
Journal:  Mol Biol Rep       Date:  2020-02-22       Impact factor: 2.316

2.  Knockdown of circRAD23B Exerts Antitumor Response in Colorectal Cancer via the Regulation of miR-1205/TRIM44 axis.

Authors:  Bingbing Han; Xiaohong Wang; Xia Yin
Journal:  Dig Dis Sci       Date:  2021-02-25       Impact factor: 3.199

3.  Comprehensive analysis of Syk gene methylation in colorectal cancer.

Authors:  Fanqin Bu; Xiaojian Zhu; Sicheng Liu; Kang Lin; Jinfeng Zhu; Jun Huang
Journal:  Immun Inflamm Dis       Date:  2021-05-12

4.  MicroRNA-506-3p inhibits colorectal cancer cell proliferation through targeting enhancer of zeste homologue 2.

Authors:  Liang Ai; Xiaojun Luo; Xiong Yan; Shan Jiang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.